An ambitious and advancing pipeline: T-cell and non-neutralizing antibody-based vaccine strategies
04 February 2021
•
SY09
•
16:15
>
17:15
•
An ambitious and advancing pipeline: T-cell and non-neutralizing antibody-based vaccine strategies
•
Live channel 2
The current HIV vaccine portfolio is both ambitious and filled with challenges. This session examines the most recent advances in prophylactic and therapeutic vaccine strategies designed to promote neutralization-independent mechanisms and elicit T cell responses with the potential to eradicate the virus.
16:15
•
SY09.01
•
Ad26 mosaic vaccine development program
See abstract
16:25
•
SY09.02
•
Mechanistic insights into prime-boost vaccination
See abstract
16:35
•
SY09.03
•
CMV-vectored vaccines for HIV prevention
See abstract
16:45
•
SY09.04
•
Refocusing T cell responses with therapeutic vaccination strategies
See abstract
16:55
•
SY09.05
•
Structural topology approaches to define T-cell epitopes
See abstract
17:05
•
SY09.06
•
Live Q&A
See abstract
|